$TBTC
TABLE TRAC INC

2017 Q2 Form 10-Q Financial Statement

#000114420417042934 Filed on August 14, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q2
Revenue $2.184M $1.922M
YoY Change 13.63% 164.66%
Cost Of Revenue $753.9K $658.9K
YoY Change 14.42% 163.22%
Gross Profit $1.430M $1.263M
YoY Change 13.22% 165.42%
Gross Profit Margin 65.48% 65.71%
Selling, General & Admin $1.193M $954.5K
YoY Change 24.96% 20.06%
% of Gross Profit 83.41% 75.58%
Research & Development $23.97K $18.27K
YoY Change 31.18% 1329.89%
% of Gross Profit 1.68% 1.45%
Depreciation & Amortization $0.00 $0.00
YoY Change
% of Gross Profit 0.0% 0.0%
Operating Expenses $1.217M $972.8K
YoY Change 25.07% 22.16%
Operating Profit $237.1K $308.4K
YoY Change -23.11% -196.62%
Interest Expense $20.00K $20.00K
YoY Change 0.0% 100.0%
% of Operating Profit 8.43% 6.48%
Other Income/Expense, Net
YoY Change
Pretax Income $261.0K $328.2K
YoY Change -20.48% -205.95%
Income Tax $96.00K $113.0K
% Of Pretax Income 36.78% 34.43%
Net Earnings $165.0K $215.2K
YoY Change -23.33% -210.48%
Net Earnings / Revenue 7.56% 11.2%
Basic Earnings Per Share
Diluted Earnings Per Share $35.48K $48.57K
COMMON SHARES
Basic Shares Outstanding 4.512M shares 4.525M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q2 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $250.0K $40.00K
YoY Change 525.0% -93.33%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $100.0K $130.0K
YoY Change -23.08% 44.44%
Inventory $660.0K $871.7K
Prepaid Expenses $125.6K
Receivables $3.500M $2.772M
Other Receivables $20.00K $70.00K
Total Short-Term Assets $4.530M $3.874M
YoY Change 16.94% -20.95%
LONG-TERM ASSETS
Property, Plant & Equipment $60.00K $43.98K
YoY Change 36.43% 119.9%
Goodwill
YoY Change
Intangibles $956.00
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $1.516M
YoY Change -100.0% 3690.18%
Total Long-Term Assets $2.260M $4.405M
YoY Change -48.69% 113.83%
TOTAL ASSETS
Total Short-Term Assets $4.530M $3.874M
Total Long-Term Assets $2.260M $4.405M
Total Assets $6.790M $8.279M
YoY Change -17.98% 18.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $340.0K $690.0K
YoY Change -50.72% 40.82%
Accrued Expenses $90.00K $40.00K
YoY Change 125.0% -50.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $20.00K $10.00K
YoY Change 100.0%
Total Short-Term Liabilities $490.0K $1.600M
YoY Change -69.37% 20.29%
LONG-TERM LIABILITIES
Long-Term Debt $30.00K $20.00K
YoY Change 50.0%
Other Long-Term Liabilities $2.660M $3.950M
YoY Change -32.66% 49.62%
Total Long-Term Liabilities $2.690M $3.970M
YoY Change -32.24% 50.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $490.0K $1.600M
Total Long-Term Liabilities $2.690M $3.970M
Total Liabilities $3.980M $5.572M
YoY Change -28.57% 40.36%
SHAREHOLDERS EQUITY
Retained Earnings $1.032M
YoY Change
Common Stock $1.811M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $136.4K
YoY Change
Treasury Stock Shares 144.8K shares 136.5K shares
Shareholders Equity $2.810M $2.706M
YoY Change
Total Liabilities & Shareholders Equity $6.790M $8.279M
YoY Change -17.98% 18.94%

Cashflow Statement

Concept 2017 Q2 2016 Q2
OPERATING ACTIVITIES
Net Income $165.0K $215.2K
YoY Change -23.33% -210.48%
Depreciation, Depletion And Amortization $0.00 $0.00
YoY Change
Cash From Operating Activities $50.00K -$310.0K
YoY Change -116.13% 0.0%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$10.00K $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -10.00K
YoY Change -100.0% -66.67%
NET CHANGE
Cash From Operating Activities 50.00K -310.0K
Cash From Investing Activities -10.00K 0.000
Cash From Financing Activities 0.000 -10.00K
Net Change In Cash 40.00K -320.0K
YoY Change -112.5% -11.11%
FREE CASH FLOW
Cash From Operating Activities $50.00K -$310.0K
Capital Expenditures -$10.00K $0.00
Free Cash Flow $60.00K -$310.0K
YoY Change -119.35% 6.9%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
44000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
33000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1214715 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
589796 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
215558 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
11236 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
12734 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-178710 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
263704 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-361515 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
276621 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-129783 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
19650 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
11116 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
62320 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1036497 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-74844 USD
us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
0 USD
us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
157566 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-229834 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
155621 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
3383 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
3573 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-23033 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-3573 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-252867 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
144673 USD
CY2015Q4 us-gaap Cash
Cash
289105 USD
CY2016Q2 us-gaap Cash
Cash
36238 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
6375 USD
CY2016Q4 tbtc Accounts Receivable Under Normal30 Days
AccountsReceivableUnderNormal30Days
979564 USD
CY2017Q2 tbtc Accounts Receivable Under Normal30 Days
AccountsReceivableUnderNormal30Days
1757619 USD
CY2016Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
2028025 USD
CY2017Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1898230 USD
CY2016Q4 us-gaap Accounts Receivable Gross Noncurrent
AccountsReceivableGrossNoncurrent
1421330 USD
CY2017Q2 us-gaap Accounts Receivable Gross Noncurrent
AccountsReceivableGrossNoncurrent
1212619 USD
CY2016Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
4428919 USD
CY2017Q2 us-gaap Accounts Receivable Gross
AccountsReceivableGross
4868468 USD
CY2016Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
4228653 USD
CY2017Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
4713367 USD
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0 USD
CY2016 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
14869 USD
CY2016 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0 USD
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
200266 USD
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
185397 USD
CY2017Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
155101 USD
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4511965 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4525584 shares
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.01
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.02
CY2017Q2 us-gaap Other Commitment
OtherCommitment
38000 USD
CY2017Q2 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
2951402 USD
CY2016Q4 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
2910785 USD
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
200266 USD
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4656734 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4656734 shares
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4511965 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4511965 shares
CY2017Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
144769 shares
CY2017Q2 us-gaap Revenues
Revenues
2183787 USD
CY2016Q2 us-gaap Revenues
Revenues
1921800 USD
us-gaap Revenues
Revenues
3284420 USD
us-gaap Revenues
Revenues
2861171 USD
CY2017Q2 us-gaap Cost Of Revenue
CostOfRevenue
753931 USD
CY2016Q2 us-gaap Cost Of Revenue
CostOfRevenue
658899 USD
us-gaap Cost Of Revenue
CostOfRevenue
1074997 USD
us-gaap Cost Of Revenue
CostOfRevenue
758486 USD
CY2017Q2 us-gaap Gross Profit
GrossProfit
1429856 USD
CY2016Q2 us-gaap Gross Profit
GrossProfit
1262901 USD
us-gaap Gross Profit
GrossProfit
2209423 USD
us-gaap Gross Profit
GrossProfit
2102685 USD
CY2017Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1192708 USD
CY2016Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
954488 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2192848 USD
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
237148 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
96650 USD
CY2017Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2911 USD
CY2016Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-3060 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-6049 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-16754 USD
CY2017Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
25251 USD
CY2016Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
22851 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
58591 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
42402 USD
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
164988 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
215204 USD
us-gaap Net Income Loss
NetIncomeLoss
40617 USD
us-gaap Net Income Loss
NetIncomeLoss
78298 USD
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.04
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.05
CY2017Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4511965 shares
CY2016Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4525457 shares
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
260988 USD
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
328204 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
70617 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
122298 USD
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
96000 USD
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
113000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
44000 USD
us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
8875 USD
us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
0 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-7375 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
0 USD
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
32435 USD
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
0 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <u>Use of Estimates</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company uses estimates and assumptions in accounting for the following significant matters, among others: revenue recognition, realizability of accounts receivable, the valuation of deferred tax assets and liabilities, deferred revenue and costs, and the valuation of inventory. Actual results could differ from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23972 USD
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18274 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
31705 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22139 USD
CY2017Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
134635 USD
CY2017Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
155101 USD
tbtc Additional Allowance For Doubtful Debts
AdditionalAllowanceForDoubtfulDebts
150000 USD
CY2017Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
1500 USD
CY2016Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
1500 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1500 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
105082 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
1500 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD

Files In Submission

Name View Source Status
0001144204-17-042934-index-headers.html Edgar Link pending
0001144204-17-042934-index.html Edgar Link pending
0001144204-17-042934.txt Edgar Link pending
0001144204-17-042934-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tbtc-20170630.xml Edgar Link completed
tbtc-20170630.xsd Edgar Link pending
tbtc-20170630_cal.xml Edgar Link unprocessable
tbtc-20170630_def.xml Edgar Link unprocessable
tbtc-20170630_lab.xml Edgar Link unprocessable
tbtc-20170630_pre.xml Edgar Link unprocessable
v471971_10q.htm Edgar Link pending
v471971_ex31.htm Edgar Link pending
v471971_ex32.htm Edgar Link pending